Related Experiment Video
Updated: Jun 9, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure
1Center for Pharmacogenomics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA. gdorn@dom.wustl.edu
Abstract:
Programmed cell elimination is an important pathological mediator of disease. Multiple pathways to programmed cell death have been delineated, including apoptosis, autophagy and programmed necrosis. Cross-talk between the signaling pathways mediating each process has made it difficult to define specific mechanisms of in vivo programmed cell death. For this reason, many "apoptotic" diseases may involve other death signaling pathways. Recent advances in genetic complementation using mouse knock-out models are helping to dissect apoptotic and necrotic cell death in different pathological states. The current state of research in this area is reviewed, focusing upon new findings describing the role of programmed necrosis induced by the mitochondrial permeability transition in mouse models of heart failure and diabetes.
Insights
Programmed cell death, including apoptosis and programmed necrosis, is key in disease. New mouse models help differentiate these pathways, revealing programmed necrosis
Area of Science:
- Cellular Biology
- Pathology
- Molecular Medicine
Background:
- Programmed cell death is a critical pathological process implicated in various diseases.
- Known pathways include apoptosis, autophagy, and programmed necrosis, but their signaling pathways often intersect.
- This cross-talk complicates the precise definition of in vivo programmed cell death mechanisms.
Purpose of the Study:
- To review the current research on programmed cell death mechanisms.
- To highlight recent advances in dissecting apoptotic and necrotic cell death using genetic models.
- To focus on the role of programmed necrosis, specifically via mitochondrial permeability transition, in heart failure and diabetes.
Main Methods:
- Review of current scientific literature and research findings.
- Utilizing genetic complementation and mouse knock-out models.
- Focusing on studies investigating the mitochondrial permeability transition in disease models.
Main Results:
- Advances in genetic models are improving the ability to distinguish between apoptotic and necrotic cell death in pathological conditions.
- Programmed necrosis, induced by mitochondrial permeability transition, plays a significant role in mouse models of heart failure.
- Programmed necrosis is also implicated in the pathogenesis of diabetes, as shown in relevant mouse models.
Conclusions:
- Differentiating between programmed cell death pathways is crucial for understanding disease.
- Programmed necrosis is an important contributor to pathology in conditions like heart failure and diabetes.
- Further research using advanced genetic models is essential for clarifying cell death mechanisms in disease.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Pathophysiology of Heart Failure
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
Heart Failure II: Pathophysiology
Cellular Injury I: Introduction